Novavax announced that  its coronavirus vaccine candidate was found to have an overall efficacy of 90.4% in a Phase 3 trial .The company said the vaccine was “generally well-tolerated” and common side effects included pain at the injection site, lasting less than three days, and fatigue, headache and muscle pain, lasting less than two days. Novavax’s coronavirus vaccine, called NVX-CoV2373, differs from the three vaccines already in use . With that efficacy , do you think that the world should open up economies ?

Previous Article

chipmaking factory fighting climate crisis and corona virus

Next Article

Bitcoin Starts to Raise